Dose-finding study of candesartan cilexetil plus hydrochlorothiazide in patients with mild to moderate hypertension

Journal of Human Hypertension

Volumn 11, Issue SUPPL. 2, 1997, Pages

  Philipp, T ^a,d   Letzel, H ^b   Arens, H J ^c  

^a UNIVERSITY OF DUISBURG ESSEN   (Germany)

^b Staticon GmbH   (Germany)

^c Takeda Pharma GmbH   (Germany)

^d UNIVERSITY HOSPITAL ESSEN   (Germany)

Author keywords

Candesartan cilexetil; Clinical study; Dose finding study; Hydrochlorothiazide

Indexed keywords

CANDESARTAN HEXETIL; HYDROCHLOROTHIAZIDE;

ADULT; AGED; ANTIHYPERTENSIVE ACTIVITY; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DRUG EFFICACY; DRUG RESPONSE; DRUG SAFETY; FEMALE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; ORAL DRUG ADMINISTRATION; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT;

ADOLESCENT; ADULT; AGED; ANTIHYPERTENSIVE AGENTS; BENZIMIDAZOLES; BIPHENYL COMPOUNDS; DIURETICS; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; HYDROCHLOROTHIAZIDE; HYPERTENSION; MALE; MIDDLE AGED; RECEPTORS, ANGIOTENSIN; SODIUM CHLORIDE SYMPORTER INHIBITORS; TETRAZOLES;

EID: 0030699198     PISSN: 09509240     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (1)

1. Opie LH. Individualised selection of antihypertensive therapy. Drugs 1993; 46 (Suppl 2): 142-148.